Protara Therapeutics, Inc. (TARA) Misses Q1 EPS by 6c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q1 EPS of ($0.97), $0.06 worse than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• RXO shares soar as C.H. Robinson announces $5.8B cash and stock buyout
• Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
• Insmed CFO Sara Bonstein to step down October 30